Miruvor
Sign up
Long COVID Outcome unclear

Long COVID, little benefit from low-dose naltrexone and a crash at higher doses

Condition
Long COVID
At worst
Not stated
Ill for
Not stated
Last post
May 2026
In their words
Read from 2 of their posts and comments; links to the 2 this page draws on

Request to remove this story

Summary

Living with long COVID, this user tried low-dose naltrexone and was fine at 0.1 to 1 mg, but slowly raising to 1.5 and then 2 mg caused an eight-week crash verified by a wearable HRV monitor. Heart-rate variability returned to their usual baseline after cutting the dose back below 1 mg. They noticed little benefit from LDN, and later linked increased sympathetic activation to adding lactoferrin.

Ask Miruvor AI

Asking aboutOrchid 90807’s story

What they tried

Their words about each treatment
  • LDN · Much worseLDN actually put me in a crash. I’m fine at .1-1 mg, but I moved up slowly to 1.5 then 2 mgs and was in an 8 week crash In context ↗
  • lactoferrin · WorseMy increased sympathetic activation correlates with adding lactoferrin FWIW (tracking with Garmin). In context ↗

Their path

They say too little about how ill they were at each step to draw it on the severity scale, so the steps are listed as they describe them. Dates are when they posted.

WhenWhat happenedAfter
2026-04-03eight-week crash after raising LDN dose to 1.5 then 2 mgI moved up slowly to 1.5 then 2 mgs and was in an 8 week crash (verified by wearable HRV monitor) In context ↗Low-dose naltrexone
2026-05-25back under 1 mg LDN, added lactoferrinI haven’t noticed much benefit In context ↗Low-dose naltrexone

Adverse events

Ask Miruvor AI

Asking aboutOrchid 90807’s story

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime